Home › Lymphoma › NCT03458520

Pediatric PET/MR Image Registry

Who can join

Up to age 40 · All sexes

Inclusion Criteria:

* Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor.
* We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs.
* Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry.

Exclusion Criteria:

* Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level \> 200 mg/dl.
* Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age).
* Patient has a CNS primary tumor.
* Pregnant women and fetuses

About the study

The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.

What is being tested

• PET/MR imaging (diagnostic test)
• MR imaging (diagnostic test)
• PET/CT imaging (diagnostic test)

Sponsor: Stanford University · Participants: 100 · Started: Feb 1, 2018

Contact the study team

• Anne Muehe · Phone: 650-720-8601

Official record on ClinicalTrials.gov — NCT03458520

Locations in the U.S.

Conditions

• Lymphoma
• Osteosarcoma

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.